Please login to the form below

Not currently logged in
Email:
Password:

AZ appoints Pam Cheng as executive VP, operations and IT

She joins from MSD China where she was president

edit-AZ-Pam-ChengAstraZeneca has named Pam Cheng as executive vice president, operations and IT.

Cheng succeeds David Smith, who is retiring after nearly ten years at the firm. She will be responsible for manufacturing operations and supply chain, procurement and information technology globally.

In the role, she will oversee AZ's progression in driving efficiency and delivering excellence within her field.

Pascal Soriot, CEO at AZ, commented: “I am delighted to welcome Pam to AstraZeneca at a very exciting time for our business. As our pipeline delivers, we will bring an increasing number of new medicines to patients across the globe over the coming years, including important biological therapies as our product mix shifts. 

“Pam will be able to bring to bear her wealth of experience in manufacturing and supply chain management, as well as her experience in emerging markets, particularly China, a key priority for our company.”

Cheng joins from Merck/MSD, where she was most recently chief operating officer and then president of MSD China.

At the company, Cheng gained extensive experience in pharma manufacturing and supply chain management as director of global planning and capacity management and head of global supply chain management and logistics. 

19th June 2015

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics